Cargando…
Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145
BACKGROUND: Epidermal Growth Factor Receptor is often overexpressed in advanced prostate carcinoma. In-vitro-studies in prostate carcinoma cell line DU145 have demonstrated increased sensibility to radiation after cetuximab treatment, but clinical data are not sufficient to date. METHODS: We analyze...
Autores principales: | Schneider, Raik, Gademann, Günther, Ochel, Hans-Joachim, Neumann, Karsten, Jandrig, Burkhard, Hass, Peter, Walke, Mathias, Schostak, Martin, Brunner, Thomas, Christoph, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317395/ https://www.ncbi.nlm.nih.gov/pubmed/34321039 http://dx.doi.org/10.1186/s13014-021-01859-6 |
Ejemplares similares
-
Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin
por: Korte, Verena, et al.
Publicado: (2022) -
Nodal and osseous oligometastatic prostate cancer: a cohort including the introduction of PSMA-PET/CT-guided stereotactic and hypofractionated radiotherapy with elective nodal therapy
por: Gawish, Ahmed, et al.
Publicado: (2022) -
Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer
por: Wallukat, Gerd, et al.
Publicado: (2020) -
Assessment of Iterative Closest Point Registration Accuracy for Different Phantom Surfaces Captured by an Optical 3D Sensor in Radiotherapy
por: Krell, Gerald, et al.
Publicado: (2017) -
A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer
por: Hochhertz, Franka, et al.
Publicado: (2022)